A-101 (Anthera)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameA-101 (Anthera)
Drug Alias NameA-101 (Anthera)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLDL cholesterol modulatorsPhospholipases A2 inhibitors
TargetsLDL cholesterolPhospholipases A2
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnthera Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnthera Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A